Carson Wealth (CWM LLC)
IRWD icon

Carson Wealth (CWM LLC)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$977K Buy
278,217
+45,233
+19% +$185K ﹤0.01% 1550
2025
Q4 		$785K Buy
232,984
+194
+0.1% +$504 ﹤0.01% 1648
2025
Q3 		$305K Buy
232,790
+50,016
+27% +$51.8K ﹤0.01% 2120
2025
Q2 		$131K Buy
182,774
+125,773
+221% +$98.7K ﹤0.01% 2490
2025
Q1 		$84K Buy
57,001
+50,675
+801% +$121K ﹤0.01% 2571
2024
Q4 		$28K Buy
6,326
+2,384
+60% +$9.67K ﹤0.01% 3223
2024
Q3 		$16K Sell
3,942
-2,658
-40% -$14.3K ﹤0.01% 3512
2024
Q2 		$43K Buy
6,600
+2,345
+55% +$16.6K ﹤0.01% 2583
2024
Q1 		$37K Buy
4,255
+3,350
+370% +$40.6K ﹤0.01% 2499
2023
Q4 		$10K Buy
905
+319
+54% +$3.15K ﹤0.01% 3181
2023
Q3 		$6K Sell
586
-739
-56% -$7.24K ﹤0.01% 3375
2023
Q2 		$14K Buy
1,325
+880
+198% +$9.46K ﹤0.01% 2870
2023
Q1 		$5K Buy
445
+62
+16% +$695 ﹤0.01% 3298
2022
Q4 		$5K Buy
383
+5
+1% +$57 ﹤0.01% 3188
2022
Q3 		$4K Buy
378
+319
+541% +$3.62K ﹤0.01% 3180
2022
Q2 		$1K Buy
59
+29
+97% +$342 ﹤0.01% 3562
2022
Q1 		$0 Buy
+30
New +$344 ﹤0.01% 3681
2019
Q1 		– Sell
-3,551
Closed -$31K – 3108
2018
Q4 		$31K Buy
+3,551
New +$40.8K ﹤0.01% 1007

Other funds holding IRWD

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s IRWD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Ironwood Pharmaceuticals (IRWD) stake by 19% in Q1 2026, buying an estimated $185K and bringing the position to 278,217 shares worth $977K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Carson Wealth (CWM LLC) first reported a position in IRWD in Q4 2018 and has held it in 18 quarters since. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 278,217 shares of Ironwood Pharmaceuticals worth $977K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 45,233 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $185K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1550 holding.
  • Carson Wealth (CWM LLC) first reported a position in Ironwood Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.